Astrana Health - ASTH STOCK NEWS

Astrana Health (NASDAQ: ASTH) has announced it will release its financial results for Q1 2025 (ending March 31, 2025) after market close on Thursday, May 8, 2025. The company will host a conference call to discuss the results at 2:30 p.m. PT/5:30 p.m. ET on the same day.

Participants can join the call using dial-in numbers (877) 858-9810 (domestic) or +1 (201) 689-8517 (international). A PDF slide presentation will be available on the company's IR Calendar webpage. The event will also be accessible via webcast, with a recording available shortly after the call's conclusion.

Astrana Health (NASDAQ: ASTH) reported its Q4 and full-year 2024 financial results, demonstrating significant growth. For FY2024, total revenue reached $2,034.5 million, up 47% year-over-year, with Care Partners revenue increasing 52% to $1,949.0 million. However, net income decreased to $43.1 million from $60.7 million in 2023.

Q4 2024 showed mixed results with total revenue up 88% to $665.2 million, but recorded a net loss of $7.0 million compared to income of $12.4 million in Q4 2023. The company secured a new credit agreement with Truist Bank, providing access to $300 million revolving credit, $250 million term loan, and $745 million delayed draw term loan facilities.

Recent highlights include a new Care Enablement partnership with Provider HealthLink in Georgia, expected to serve 10,000 Medicare Advantage members. Additionally, eight Astrana affiliates achieved Elite status in APG's 2024 Standards of Excellence survey.

Astrana Health (NASDAQ: ASTH), a provider-centric healthcare technology company, has announced its participation in five major investor conferences in March 2025. President and CEO Brandon Sim will represent the company at:

• TD Cowen 45th Annual Health Care Conference in Boston (March 3)
• Jefferies Value-Based Healthcare Summit in Miami (March 10)
• Barclays 27th Annual Global Healthcare Conference in Miami (March 11)
• Oppenheimer 35th Annual Healthcare Conference (Virtual, March 17)
• KeyBanc Capital Markets Healthcare Forum (Virtual, March 18)

At the Jefferies summit, Sim will participate in panel discussions on Value-Based Policy and Technology/AI in VBC, along with a fireside chat. The other conferences will feature presentations and fireside chats, with webcasts available through the company's IR Calendar webpage.

Astrana Health (NASDAQ: ASTH) has scheduled its fourth quarter and full year 2024 financial results release for Thursday, February 27, 2025, after market close. The company will host a conference call at 2:30 p.m. PT/5:30 p.m. ET on the same day to discuss the results.

Participants can join the call using the dial-in numbers (877) 858-9810 for domestic callers or +1 (201) 689-8517 for international callers. An accompanying slide presentation will be available on the company's IR Calendar webpage. The call will also be accessible via webcast, with a recording available shortly after the live event.

Astrana Health (NASDAQ: ASTH) has announced a significant share repurchase of 300,000 shares from Allied Physicians of California (APC), a consolidated affiliate and long-standing stockholder. The transaction, completed on January 17, 2025, was executed at $35.17 per share, totaling $10.551 million.

The repurchase price was based on the closing price of Astrana's shares on the Nasdaq Stock Market on the transaction date. The company's Board of Directors and Audit Committee approved the transaction, with CEO Brandon K. Sim stating that the repurchase demonstrates management's confidence in Astrana Health's performance and commitment to strategic capital deployment practices focused on long-term growth.

Astrana Health (NASDAQ: ASTH) has announced its participation in the upcoming J.P. Morgan 2025 Healthcare Conference in San Francisco. The company's President and CEO, Brandon Sim, is scheduled to deliver a presentation on Tuesday, January 14, 2024, at 10:30 AM PT.

As a provider-centric, technology-powered healthcare company focused on delivering accessible, high-quality, and high-value care, Astrana will make the webcast link and presentation materials available through the 'IR Calendar' section of their corporate website at https://ir.astranahealth.com/news-events/ir-calendar.

Astrana Health announces that eight of its affiliates have achieved Elite status in America's Physician Groups' 2024 Standards of Excellence™ survey. The recognition demonstrates their excellence in delivering coordinated, patient-centered, and cost-effective care. Brandon Sim, President and CEO, highlighted this achievement as evidence of their providers' dedication to patient care.

The awarded affiliates include Access Primary Care Medical Group, Accountable Health Care IPA, and six other groups, all receiving the highest Elite 5-star status across all categories. The APG SOE® survey, now in its 17th year, evaluates healthcare delivery capabilities including health information technology, population health management, patient-centered care, and accountability for costs and quality outcomes.

Astrana Health (NASDAQ: ASTH) has announced a definitive agreement to acquire Prospect Health for $745 million. The acquisition includes Prospect's health plan, medical groups across four states, management service organization, pharmacy, and a 177-bed hospital. Prospect's network includes approximately 3,000 primary care providers and 10,000 specialists, serving 610,000 members across Medicare Advantage, Medicaid, and Commercial lines.

The transaction is expected to close in mid-2025, funded through cash and a $1,095 million bridge commitment from Truist Bank and J.P. Morgan. Prospect is projected to generate $1.2 billion in revenue with adjusted EBITDA of $81 million for 2024.

Astrana Health (NASDAQ: ASTH) reported Q3 2024 financial results with total revenue of $478.7 million, up 37% year-over-year. Care Partners revenue increased 42% to $455.8 million. However, net income declined 27% to $16.1 million, with diluted EPS falling 30% to $0.33. Adjusted EBITDA decreased 13% to $45.2 million.

The company recently acquired Collaborative Health Systems and related entities for $37.5 million plus potential earnout payments up to $21.5 million. Astrana updated its 2024 guidance, projecting total revenue between $1,950-$2,030 million and net income of $52-$58 million.